Immediate Impact
1 from Science/Nature 59 standout
Citing Papers
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Carla Perez being referenced
Dynamic risk profiling of HCC recurrence after curative intent liver resection
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Carla Perez | 118 | 21 | 40 | 93 | 74 | 12 | 267 | |
| Leyla Telhan | 86 | 26 | 6 | 26 | 15 | 16 | 326 | |
| Saja Asakrah | 127 | 22 | 6 | 9 | 60 | 12 | 328 | |
| E. E. Petersen | 119 | 30 | 19 | 24 | 112 | 20 | 266 | |
| A T Nayagam | 168 | 36 | 3 | 19 | 54 | 12 | 283 | |
| Angela Nowag | 154 | 17 | 13 | 51 | 4 | 16 | 267 | |
| Ngo Tat Trung | 125 | 24 | 42 | 5 | 13 | 22 | 309 | |
| A. Mewis | 101 | 34 | 7 | 15 | 12 | 14 | 241 | |
| Jian Deng | 39 | 43 | 12 | 17 | 14 | 11 | 318 | |
| Laishram Chandreshwor Singh | 107 | 18 | 3 | 10 | 16 | 14 | 334 | |
| Estela Isabel Bini | 93 | 44 | 2 | 22 | 19 | 18 | 318 |
All Works
Login with ORCID to disown or claim papers
Loading papers...